CRP and rheumatoid arthritis: However, a follow-up study demonstrated that auto-antibody-negative RA-patients with high baseline CRP-levels also have a subsequent stronger decline in CRP-levels during the first year of DMARD-treatment, stronger than patients who do not achieve SDFR [30].